Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
23.89
+0.23 (0.95%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $2.99 billion as of September 4, 2026. Its market cap has increased by 56.52% in one year.
Market Cap
2.99B
Enterprise Value
2.87B
1-Year Change
56.52%
Ranking
Category
Stock Price
$23.89
ChartMarket Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $2.99B, an increase of 282.52%. That is a compound annual growth rate of 22.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.99B | -15.90% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| uniQure | 3.32B |
| Tarsus Pharmaceuticals | 3.25B |
| Celldex Therapeutics | 3.08B |
| Immunome | 3.07B |
| Disc Medicine | 3.02B |
| NewAmsterdam Pharma Company | 2.98B |
| MBX Biosciences | 2.93B |
| Beam Therapeutics | 2.90B |